Article
Detection of BRCA1/2 large genomic rearrangement including BRCA1 promoter-region deletions using next-generation sequencing.
Clinica chimica acta; international journal of clinical chemistry - 1 Jun 2020
Han Eunhee, Yoo Jaeeun, Chae Hyojin, Lee Seungok, Kim Do-Hoon, Kim Kwang Joong, Kim Yonggoo, Kim Myungshin
Abstract excerpt
BACKGROUND: Germline mutations in BRCA1 and BRCA2 (BRCA1/2) have been conventionally analyzed by Sanger sequencing and multiplex ligation-dependent probe amplification (MLPA). Nowadays, next-generation sequencing (NGS) is increasingly being used in clinical genetics. The aim of this study was to evaluate the performance of NGS BRCA1/2 assays by comparing them with the conventional method. MATERIALS AND METHODS:...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
